Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
JCI Insight
|
April 10, 2023
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
Christian Nusshag, Changli Wei, Eunsil Hahm, et al.
Nature Medicine
|
May 12, 2015
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
Mario Schiffer, Beina Teng, Changkyu Gu, et al.
JAMA Pediatrics
|
September 6, 2017
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Franz Schaefer, Howard Trachtman, Elke Wühl, et al.
The Journal of Clinical Investigation
|
February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei, Jing Li, Brian D Adair, et al.
The New England Journal of Medicine
|
January 30, 2020
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S Hayek, David E Leaf, Ayman Samman Tahhan, et al.
The Journal of Clinical Investigation
|
September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival
Suma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Nature Medicine
|
August 2, 2011
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei, Shafic El Hindi, Jing Li, et al.
Nature Medicine
|
June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney disease
Salim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
The Journal of Clinical Investigation
|
October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
George Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
JCI Insight
|
April 10, 2023
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
Christian Nusshag, Changli Wei, Eunsil Hahm, et al.
Nature Medicine
|
May 12, 2015
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
Mario Schiffer, Beina Teng, Changkyu Gu, et al.
JAMA Pediatrics
|
September 6, 2017
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Franz Schaefer, Howard Trachtman, Elke Wühl, et al.
The Journal of Clinical Investigation
|
February 8, 2019
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Changli Wei, Jing Li, Brian D Adair, et al.
The New England Journal of Medicine
|
January 30, 2020
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S Hayek, David E Leaf, Ayman Samman Tahhan, et al.
The Journal of Clinical Investigation
|
September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival
Suma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Nature Medicine
|
August 2, 2011
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei, Shafic El Hindi, Jing Li, et al.
Nature Medicine
|
June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney disease
Salim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
The Journal of Clinical Investigation
|
October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
George Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Page
of 8